ResMed R&D increased by 3.6% to $94.27M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.3%, from $83.94M to $94.27M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 10.1% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $59.88M | $59.95M | $62.51M | $66.80M | $64.32M | $63.19M | $69.87M | $76.44M | $78.14M | $75.71M | $73.88M | $77.07M | $80.86M | $79.52M | $81.37M | $83.94M | $86.44M | $87.32M | $90.97M | $94.27M |
| QoQ Change | — | +0.1% | +4.3% | +6.9% | -3.7% | -1.8% | +10.6% | +9.4% | +2.2% | -3.1% | -2.4% | +4.3% | +4.9% | -1.7% | +2.3% | +3.2% | +3.0% | +1.0% | +4.2% | +3.6% |
| YoY Change | — | — | — | — | +7.4% | +5.4% | +11.8% | +14.4% | +21.5% | +19.8% | +5.7% | +0.8% | +3.5% | +5.0% | +10.1% | +8.9% | +6.9% | +9.8% | +11.8% | +12.3% |
Range$59.88M – $94.27M
CAGR+10.0%
Avg YoY Growth+9.7%
Median YoY Growth+9.4%
Current Streak6 quarters growth
Business Segments
| Segment | Q1 '26 |
|---|---|
| Sleep And Breathing Health | $56.41M |
| Residential Care Software | $26.23M |
| Total | $94.27M |
R&D at Other Companies
Frequently Asked Questions
- What is ResMed's r&d?
- ResMed (RMD) reported r&d of $94.27M in Q1 2026.
- How has ResMed's r&d changed year-over-year?
- ResMed's r&d increased by 12.3% year-over-year, from $83.94M to $94.27M.
- What is the long-term trend for ResMed's r&d?
- Over 4 years (2021 to 2025), ResMed's r&d has grown at a 10.1% compound annual growth rate (CAGR), from $225.28M to $331.28M.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.